Position in NBIX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$4,621,198
+$974,767 QoQ
Shares Held
27,419
-0.9% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#220
of 768 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026XPONANCE LLC holds $26,283,345 across 23 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (17.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
109,299 | $7,854,226 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
27,419 | $4,621,198 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
7,508 | $4,068,059 | |
| 4 | VTRS |
Viatris Inc
|
128,327 | $2,037,832 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
59,638 | $1,467,691 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
31,419 | $1,089,296 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
9,599 | $1,064,913 | |
| 8 | ALKS |
Alkermes plc.
|
16,250 | $851,500 |
All Filings in NBIX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,621,198 | 27,419 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $3,646,431 | 27,679 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $3,547,168 | 25,010 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,704,347 | 26,388 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,264,797 | 25,975 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,017,389 | 27,282 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $3,694,645 | 27,067 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $2,895,017 | 25,126 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,473,138 | 25,228 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,539,578 | 25,664 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,825,988 | 21,448 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $2,518,200 | 22,384 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $2,115,997 | 22,439 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $2,299,515 | 22,718 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $2,667,334 | 22,332 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $2,222,125 | 20,922 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $2,033,920 | 20,865 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $1,905,750 | 20,328 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $1,739,171 | 20,420 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $1,961,934 | 20,456 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $2,006,251 | 20,615 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,893,360 | 19,469 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $913,546 | 9,531 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $925,732 | 9,627 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $1,163,026 | 9,533 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||